Form 4: DBV Technologies Chief Medical Officer Sells Shares to Cover Tax Obligations

DBV Technologies' Chief Medical Officer, Pharis Mohideen, sold a total of 907 ordinary shares to cover tax obligations related to vesting restricted stock units.

Summary

• Pharis Mohideen, the Chief Medical Officer of DBV Technologies, sold 342 ordinary shares on November 22, 2024, at a price of $0.53 per share.
• He then sold an additional 565 ordinary shares on November 25, 2024, at a price of $0.57 per share.
• These sales were made to satisfy withholding tax obligations arising from the vesting of restricted stock units.
• The sales resulted in a decrease in his direct holdings of ordinary shares from 112,017 to 111,110.
• The prices are based on the conversion of Euro to USD at exchange rates of $1.0469 and $1.048 to 1 Euro on the respective dates.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any significant positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive share sales to cover tax obligations are a common practice across the biotechnology industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar sales when these units vest.
• The sale prices are within the range of recent trading activity for DBV Technologies shares.

Stakeholder Impact

• The share sales have a minimal impact on shareholders as they are routine transactions.
• The sales do not indicate any change in the company's performance or outlook.

Key Dates

Keywords

DBV Technologies, Pharis Mohideen, Chief Medical Officer, share sale, insider trading, restricted stock units, tax obligations, ordinary shares